Valproate in the treatment of absence epilepsy in children: a study of dose-response relationships

Epilepsia. 1988 Sep-Oct;29(5):548-52. doi: 10.1111/j.1528-1157.1988.tb03759.x.

Abstract

Seven children with absence epilepsy were treated with valproate (VPA). All but one child became free of absence seizures during VPA monotherapy. EEG was recorded for 24 h before start of VPA treatment and repeatedly during treatment. Correlation between plasma VPA concentration and reduction of the number of epileptic discharges was significant. Plasma concentration of 440-660 microM VPA was needed to achieve at least 50% reduction of seizure activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Child
  • Dose-Response Relationship, Drug
  • Epilepsy, Absence / blood
  • Epilepsy, Absence / drug therapy*
  • Female
  • Humans
  • Male
  • Valproic Acid / blood
  • Valproic Acid / therapeutic use*

Substances

  • Valproic Acid